Loading…
Underlying
Underlying Price
$38.90
Type
Call
Strike
40
Expiration
Nov 27, 2026
DTE
34d
Moneyness
OTM
Intrinsic
$0.00
NVO 40 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $0.10 | +0.00% | 1,402 | 4,386 |
| Oct 30, 2026 | 6d | $0.54 | +25.58% | 659 | 5,471 |
| Nov 6, 2026 | 13d | $1.31 | +4.80% | 51 | 874 |
| Nov 13, 2026 | 20d | $1.57 | +18.94% | 34 | 166 |
| Nov 20, 2026 | 27d | $1.56 | +6.12% | 686 | 11,961 |
| Nov 27, 2026 | 34d | $1.89 | +18.12% | 3 | 94 |
| Dec 18, 2026 | 55d | $2.05 | +4.59% | 435 | 8,145 |
| Jan 15, 2027 | 83d | $2.58 | +7.05% | 371 | 15,399 |
| Mar 19, 2027 | 146d | $3.79 | +2.43% | 74 | 4,839 |
| Jun 17, 2027 | 236d | $4.75 | +4.40% | 31 | 3,593 |
| Sep 17, 2027 | 328d | $5.65 | +0.89% | 13 | 808 |
| Dec 17, 2027 | 419d | $6.50 | +0.62% | 268 | 3,321 |
| Jan 21, 2028 | 454d | $6.80 | +1.64% | 437 | 14,641 |
| Jun 16, 2028 | 601d | $7.90 | -1.25% | 15 | 369 |
| Dec 15, 2028 | 783d | $9.10 | +0.00% | 1 | 2,099 |
| Jan 19, 2029 | 818d | $9.29 | +3.22% | 23 | 592 |
NVO Nearby Strikes · Nov 27, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 34 C | — | — | 0 | 0 | ITM |
| 35 C | $4.05 | +0.00% | 4 | 4 | ITM |
| 36 C | $4.15 | +0.00% | 2 | 2 | ITM |
| 37 C | $2.84 | +0.00% | 1 | 1 | ITM |
| 38 C | $2.16 | -11.48% | 2 | 2 | ITM |
| 39 C | $2.32 | +12.08% | 2 | 580 | OTM |
| 40 C | $1.89 | +18.12% | 3 | 94 | OTM |
| 41 C | $1.40 | +16.67% | 13 | 78 | OTM |
| 42 C | $1.03 | +27.16% | 41 | 130 | OTM |
| 43 C | $0.74 | +2.78% | 123 | 212 | OTM |
| 44 C | $0.58 | +5.45% | 26 | 71 | OTM |
| 45 C | $0.42 | +16.67% | 9 | 81 | OTM |
| 46 C | $0.31 | -18.42% | 5 | 12 | OTM |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.